TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Plaque Instability (MRI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plaque Instability (Histopathology)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analogue Scale (VAS) of Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of iron deficiency anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Amount of physical activity in minutes per day
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: EQ VAS / EQ-5D-5L
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change From Baseline in 6-Minute Walk Distance (6MWD) at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Gastroparesis as an early sign for sepsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Correlation of PET-MRI PSMA signal intensity and glioma protein concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve (AUC) From Time of Administration to Last Observed Plasma Concentration (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC From Time of Administration to Infinity (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of congruence between informed values and treatment choice
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Participant's satisfaction with ability to write neuro-strength-based goals
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Participants' knowledge of clinical reasoning for goals
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: 7-day Quit Attempts
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pressure data from the insoles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic performance of identifying pathogens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Western Ontario and McMaster Universities Arthritis Index (WOMAC) osteoarthritis index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in blood flow response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in limb vascular resistance response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Changes in adaptive behavior function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in seizure frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Suicide ideation at 3 months post-discharge
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Suicide ideation at 12 months post-discharge
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: COVID-19 infection spectra
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Degree to which healthcare and society is meeting needs of PLwO
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ease of use of Flexible Nasopharyngoscope
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: skin conductance synchrony
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in aspartate aminotransferase (AST) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in lactate dehydrogenase levels (LDH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: incidence of adverse events of INR101 injection
Endpoint domain: Adverse events/effects
Primary endpoint: Physician assessment of objective patient understanding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective evaluation of education by the patient
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cancer Fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: change from baseline circumference of both arms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change from baseline volume of both arms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: European Quality of Life Five Dimensions
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: COVID-19 Yorkshire Rehabilitation Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Antral content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: pathological complete regression rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Dose-Limiting Toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: HbA1c level in blood plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Management effectiveness of pulmonary nodules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Safety issues while using Pulsenmore ES device
Endpoint domain: Adverse events/effects
Primary endpoint: User error while using Pulsenmore ES device
Endpoint domain: Adverse events/effects
Primary endpoint: Internalized Homophobia Scale (IHP)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sexual Orientation Implicit Association Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Coping Self Efficacy Scale (CSES)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Beck Depression Inventory-II score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Speech Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech Fillers Mid-Phrase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech Fillers Other
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Repairs Plus False Starts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contact Lens Dry Eye Questionnaire (CLDEQ-4)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Relative Peak Power Output
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative Mean Power Output
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Sprint Decrement Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in KOOS4 scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: American Shoulder and Elbow Surgeons Shoulder (ASES) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of adverse reactions within 28 days after the booster dose
Endpoint domain: Adverse events/effects
Primary endpoint: GMT of neutralizing antibodies against live SARS-CoV-2 virus on day 28 after the booster dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in children's wellbeing: psychiatric symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in children's wellbeing: health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Composite of fatal or nonfatal ischemic stroke, type I myocardial infarction, and acute limb events
Endpoint domain: Mortality/survival
Primary endpoint: Composite of non-fatal ischemic stroke, type I myocardial infarction, acute limb events, or cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: Knee injury and Osteoarthritis Outcome Score subscore Quality of Life (KOOS QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Physiological stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuropsychological domains
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Emotional-behavioral problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Abnormal findings in vital signs
Endpoint domain: Adverse events/effects
Primary endpoint: Abnormal findings in clinical laboratory assessments
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants who achieve survival
Endpoint domain: Mortality/survival
Primary endpoint: Histological Features
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Knowledge and attitudes of dialysis centers medical workers toward living kidney donations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perioperative blood loss (haemoglobin balance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Complete occlusion rate of aneurysms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Central macular thickness (CMT change)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Best corrected visual acuity (BCVA change)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Oxygen Uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Peak Pulmonary Capillary Wedge Pressure (PCWP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of completed tele-health visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change from baseline in sleep duration
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change from baseline in Sleep timing
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change from baseline in Circadian alignment
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Cranio-vertebral angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WaLLID Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Smoking Point-Prevalence Abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximal isometric hamstring strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: concentration of Hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: concentration of Serum albumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: concentration of Serum prealbumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fasting blood LDL cholesterol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Perceived message effectiveness for motivation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Kujala scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantification of hypoxic tumor volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Fasciitis pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plantar fascia thickness in mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inhaler adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proprioception ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Placenta volume in ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fetal liver volume in ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ductus venosus volume in ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time consumed to identify the epidural space
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Performance Index (PI) Relative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wisconsin Card Sorting Test (WCST): Proportion of perseverative errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Backwards Digit Span (BDS): Total items correct
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Punctate mechanical hyperalgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wind-up phenomenon
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression of colonic (NF)-κB proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Financial consequences
Endpoint domain: Resource use
Primary endpoint: Diagnosis of catheter related bloodstream infection
Endpoint domain: Adverse events/effects
Primary endpoint: Healing rate of intra oral sinus tract
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of radiotherapy-induced hypopituitarism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Elderly functional Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate of grade 3+ infections
Endpoint domain: Adverse events/effects
Primary endpoint: Puff Topography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trachea diameter measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Main bronchi length measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Main bronchi diameter measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Acute Subjective Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Efficacy at 1 month of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Western Ontario and McMaster Universities Arthritis Index-total
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of gastric outlet obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Diaper dermatitis healing scale result
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Dyspnea measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery of left atrial functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recovery of left ventricular function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Gait related parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants who Develop End of Dose Symptoms (EOD)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in urinary excretion of 13^C-mannitol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Body mass index (BMI) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: retrieval rates of the Magseed Pro® marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Postprandial Serum Lipids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sensitivity of SeizureWise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants with clinically significant changes from baseline in clinical laboratory values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentrations of lofexidine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: galectin-3 levels in GCF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: galectin-3 levels in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hyperlactatemia levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in oral pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-operative anxiety level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline disease activity score (DAS28)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-free-rate at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change on social anxiety symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to stable sputum conversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of subjects with postoperative delirium accurately predicted by the PIPRA Tool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sensitivity of CADx-assisted optical diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Receiver operator characteristic curve (ROC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of high level of Lp(a)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximum observed concentration (Cmax) of sulfasalazine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of sulfapyridine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve from time zero to infinity (AUC0-inf) of sulfasalazine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-inf of sulfapyridine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sulfapyridine to sulfasalazine AUC ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in whole blood haemoglobin enrichment with iron-57
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Social behavior
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Repetitive behaviour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variations of urinary cortisol metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Plasmatic total BA level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Back pain intensity during menstruation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline of Skin's surface Profilometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Physician-Assessed Adverse Breast Cosmesis
Endpoint domain: Adverse events/effects
Primary endpoint: Impaired Social Participation
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Modified Hamilton Rating Scale for Depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PROMIS Ability to Participate in Social Roles and Activities
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Patient satisfaction with the intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of patients with AEs and SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Time to First Relapse (TTFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with disability progression as measured by the EDSS over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the time-concentration curve in milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of HPC in Egyptian Children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of HSPM in Egyptian Children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: amount of opioid consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma concentration observed (Cmax) of ITF2357
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration versus time curve to the real time tlast (AUClast) of ITF2357
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration versus time curve extrapolated to infinity (AUC0-inf) of ITF2357
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in IIEF score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in MSHQ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in OAB-SF score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes